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Brief Definit ive Report
Loss-of-function studies have shown that cyto-
kines have specific roles in maintaining lineage 
output during steady-state hematopoiesis by 
promoting the survival and expansion of com-
mitted progenitors (Metcalf, 2008). However, 
further studies have shown that endogenous 
myeloid cytokine receptors direct lineage choice 
of stem and progenitor cells (Rieger et al., 2009; 
Mossadegh-Keller et al., 2013), raising the pos-
sibility that this is a general cytokine function.
Elevated levels of hematopoietic cytokines 
increase the production of specific cell types in 
response to physiological emergencies such as 
hypoxia, anemia, or infection, where levels of 
circulating erythropoietin (Epo) and myeloid 
colony stimulating factors can increase by several 
orders of magnitude (Cheers et al., 1988; Watari 
et al., 1989). During severe anemia, Epo serum 
levels are elevated up to 1,000-fold (Jelkmann 
and Wiedemann, 1990), increasing exponentially 
to the degree of anemia. The Epo–Epo receptor 
signaling pathway, although dispensable for the 
formation of erythroid progenitors, is essential 
for their subsequent proliferation and survival 
(Wu et al., 1995; Lin et al., 1996). The effect 
of increased Epo production is therefore gener-
ally believed to be due to improved expansion 
of committed erythroid progenitors (Metcalf, 
2008). Multipotent hematopoietic cells have 
been shown to express functional Epo receptor 
(Shiozawa et al., 2010), but the effect of elevated 
systemic Epo levels on non-erythroid hemato-
poietic lineages and multipotent stem cells and 
progenitors remains essentially unknown.
We observe here that elevated systemic 
Epo levels suppress the levels of phenotypic 
and functional non-erythroid progenitors in 
the bone marrow, and transplantation of Epo-
exposed multipotent stem/progenitor cells re-
sults in an erythroid-biased lineage output. Epo 
therefore acts directly on multipotent hemato-
poietic cells to alter their progenitor and ma-
ture cell output.
RESULTS AND DISCUSSION
We developed a model where systemic Epo 
levels were selectively increased through hydro-
dynamic tail vein injection (Zhang et al., 1999) 
of a CMV-based Epo expression vector, lead-
ing to increased peripheral blood erythrocyte 
numbers (unpublished data). To determine any 
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The erythroid stress cytokine erythropoietin (Epo) supports the development of committed 
erythroid progenitors, but its ability to act on upstream, multipotent cells remains to be 
established. We observe that high systemic levels of Epo reprogram the transcriptomes of 
multi- and bipotent hematopoietic stem/progenitor cells in vivo. This induces erythroid 
lineage bias at all lineage bifurcations known to exist between hematopoietic stem cells 
(HSCs) and committed erythroid progenitors, leading to increased erythroid and decreased 
myeloid HSC output. Epo, therefore, has a lineage instructive role in vivo, through suppres-
sion of non-erythroid fate options, demonstrating the ability of a cytokine to systemati-
cally bias successive lineage choices in favor of the generation of a specific cell type.
© 2014 Grover et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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Plating LinSca-1c-Kit+ progenitor cells under conditions 
specifically promoting erythroid (E), megakaryocyte (Mk), 
B-lymphoid (B), or granulocyte/macrophage (GM) differ-
entiation showed a significant decrease in GM, Mk, and B 
colony–forming cells, whereas E colony numbers were un-
changed (Fig. 1 C). The increase in circulating Epo levels ob-
tained through hydrodynamic injection were comparable to 
those observed in anemic patients (Jelkmann and Wiedemann, 
1990), whereas no change was observed in other lineage- 
specific cytokines (Thrombopoietin, G-CSF; Fig. 1 D).
preceding effect on erythroid progenitor numbers, we iso-
lated the bone marrow LinSca-1c-Kit+ population, which 
contains the myelo-erythroid progenitors (Akashi et al., 2000), 
including CFU-E and proerythroblasts (Pronk et al., 2007), at 
2 d after injection, and plated these cells under conditions 
permissive for both myeloid and erythroid differentiation. 
Staining of the developed colonies using 2,7-diaminofluor-
ene (DAF) to detect hemoglobin showed an increase in the 
proportion of erythroid colonies (Fig. 1 A). However, this was 
accompanied by a decrease in the total colony number (Fig. 1 B). 
Figure 1. Systemic Epo treatment introduces E bias  
in myelo-erythroid progenitor and LMPP production.  
(A) In vitro E differentiation potential of 500 bone marrow 
LinSca-1c-Kit+ cells isolated after 2 d of Epo treatment (Epo) 
or mock treatment (control), measured by 2,7-diaminofluorene 
(DAF) staining of M3434 methylcellulose cultures after 8 d of 
culture. Values are mean ± SD, n = 3. One of two representative 
experiments is shown. (B) Total colonies formed from cells plated 
in A. (C) Colony-forming potential of 2-d Epo-exposed or control 
LinSca-1c-Kit+ bone marrow cells was assayed separately 
under GM (M3534; 500 cells), E (M3436; 1,000 cells), preB 
(M3630; 1,000 cells), and Mk (MegaCult; 500 cells) conditions. 
Values are mean ± SD, n = 3. One of two representative experi-
ments is shown. (D) Bar graph showing serum cytokine levels in 
mice hydrodynamically injected with pCMV6-Epo or empty 
pCMV6 vector 2 d after transfection. Values are mean ± SD,  
n = 8, from two experiments. (E) Bar graphs showing total bone 
marrow cellularity (femurs and tibiae) in mice hydrodynamically 
injected with pCMV6-Epo vector (Epo; n = 6) or pCMV6 vector 
(control; n = 5), as indicated. Analysis was performed 2 d after 
injection. Values are mean ± SD, n = 5 (control) and 6 (Epo). One 
of three representative experiments is shown. (F) Bar graphs 
showing LinSca1c-Kit+IL7r myelo-erythroid progenitor 
cells from mice in E as percentage of live singlets. (G) Represen-
tative flow cytometric analysis of the hematopoietic myelo-
erythroid progenitor population from bone marrow of wild-type 
C57BL/6 mice after 2 d of Epo exposure. The size of gated popu-
lations as percentage of the parental population is shown next 
to each gate. (H) Bar graphs representing the mean size of each 
myelo-erythroid progenitor population as defined in G, shown 
as percentage of the total Lin/Sca-1/IL7Rc-Kit+ progenitor 
fraction in 2-d Epo-exposed (Epo) and control mice. Values are 
mean ± SD, n = 5, from two experiments. (I) Bar graphs repre-
sent the frequencies of LSK subpopulations in bone marrow of 
2-d Epo-exposed and control mice. Values are mean ± SD, n = 4. 
One of two representative experiments is shown. *, P < 0.05;  
**, P < 0.005; ***, P < 0.0005.
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decreased (Fig. 1, G and H). Similar skewing of myelo-erythroid 
progenitor numbers was observed upon injection of recombinant 
Epo (unpublished data). To determine if lineage skewing oc-
curred in the upstream LinSca-1+c-Kit+ (LSK) hematopoietic 
stem cell (HSC)/multipotent progenitor (MPP) compartment, 
this population was analyzed for Flt3 expression, which is 
normally associated with loss of Mk/E potential and increased 
lymphoid potential (Adolfsson et al., 2005). We observed that 
the proportion of Flt3hi lymphoid-primed MPPs (LMPPs; 
Adolfsson et al., 2005) was decreased upon Epo exposure 
(Fig. 1 I), consistent with the observed suppression of lymphoid 
This observation was at variance with the notion that 
Epo acts primarily as a proliferation/survival factor of E 
lineage–committed cells, attributing the relative increase in 
erythropoiesis, at least in part, to suppression of alternative dif-
ferentiation programs. Further analysis showed that elevated 
systemic Epo did not affect bone marrow cellularity (Fig. 1 E) or 
the proportion of total myeloid progenitors (Fig. 1 F). How-
ever, flow cytometry–based progenitor phenotyping (Pronk 
et al., 2007) showed that committed E progenitors (preCFU-E 
and CFU-E) were increased, whereas committed GM pro-
genitors (GMP and preGM) and Mk progenitors (MkPs) were 
Figure 2. Epo transcriptionally repro-
grams HSCs and progenitors in vivo  
toward an erythroid fate. (A) Bar graphs 
showing the expression of preCFU-E, preGM, 
and MkP genes in in vivo, comparing Epo-
exposed and control LSKFlt3 cells. Data are 
shown as log2 of the ratio between Epo- 
exposed and control cells. Values are means,  
n = 9, from 3 experiments. (B) Bar graphs 
showing mean size of LinSca-1+c-Kit+ (LSK) 
population as percentage of live singlets in 
mice hydrodynamically injected with pCMV6-
Epo vector or pCMV6 control vector on day 2 
after injection. Values are mean ± SD, n = 5  
(control) and 6 (Epo), from 2 experiments.  
(C) LSK cells from B were subdivided by CD150 
and CD48 expression into MPPs (defined as 
LSKCD48+CD150+ or LSKCD48+CD150) and 
primitive HSCs (defined as LSKCD48CD150+). 
The proportion of cells in the indicated frac-
tions is shown as a percentage of the total 
LSK population. Values are mean ± SD. No 
significant difference (defined as P < 0.05) 
was observed between control and Epo-
treated populations. (D) MPPs (LSKCD48+) and 
HSCs (LSKCD48CD150+) from mice hydrody-
namically injected with pCMV6-mEpo vector 
(Epo, n = 3) or pCMV6 vector (control, n = 3) 
were analyzed on day 2 after injection for cell 
cycle status by intracellular staining for Ki67 
and DNA content. G0 was defined as Ki67, 
G1 as Ki67+/2n DNA content, and S/G2/M as 
Ki67+/>2n DNA content. LinSca-1c-Kit+ 
(LSK+) progenitors are included as a posi-
tive control for high proliferation rate. Values 
are mean ± SD, n = 3. One of two representa-
tive experiments shown. (E) Expression of 
preCFU-E and MkP genes in in vivo Epo- 
exposed and control preMegEs. Data are repre-
sented as in A. (F) Expression of CLP and 
preGM genes in in vivo Epo-exposed and con-
trol LMPP. Data are represented as in A.  
(G) B cell potential of single Epo-exposed and 
control LSKFlt3hi LMPPs cultured on OP9  
stromal cells. Representative FACS profiles of 
analyzed clone derived from a single cell are shown in Fig. S2 A. Values are mean ± SD, n = 48, from 2 experiments. (H) Bar graphs showing the number of 
CLPs as percentage of total live BM cells from Epo-exposed and control mice. Values are mean ± SD, n = 5. One of two representative experiments shown. 
*, P < 0.05; **, P < 0.005; ***, P < 0.0005; N.S., not significant.
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and MkP genes (Fig. 3 C). This divergent regulation was dis-
rupted in the Gata1-deficient CD45.2 cells exposed to the same 
Epo levels (unpublished data). Transcriptional HSC reprogram-
ming therefore occurs in response to exogenous Epo, to endoge-
nous stress erythropoiesis, and to direct in vitro Epo stimulation 
and is at least partially GATA-1–dependent.
There are several signaling pathways that emanate from 
the Epo receptor, including the phosphoinositol-3 (PI3) kinase/
Akt, Erk/MAPK, and JAK–STAT pathways (Richmond et al., 
2005). To determine their individual contributions to Epo-
induced transcriptional reprogramming, LSKFlt3CD150+ 
HSCs were exposed to Epo in vitro in the presence of inhibi-
tors specific for these pathways (Fig. 3 D). We observed that 
up-regulation of preCFU-E genes was consistently depen-
dent on PI3 kinase activation, whereas JAK/STAT and Erk 
activation was involved in a gene-specific manner. In contrast, 
preGM gene expression was not significantly affected by PI3 
kinase inhibition, whereas, remarkably, Erk inhibition converted 
the normal inhibition by Epo to robust up-regulation. The 
major Epo-activated signaling pathways therefore play distinct 
and lineage-specific roles in reprogramming of the HSC tran-
scriptome. We have previously shown that loss of C/EBP func-
tion leads to loss of myeloid programming in LSKFlt3CD150+ 
HSC/MPPs (Bereshchenko et al., 2009). Direct regulation of 
myeloid genes by C/EBP may therefore explain the highly co-
ordinated regulation of preGM genes upon inhibitor treatment.
To further investigate the cellular mechanism underlying 
Epo-induced transcriptional reprogramming, we performed 
single cell gene expression profiling of control and Epo ex-
posed LSKFlt3 HSCs. We investigated the expression of 
GM (Mpo, Erg, Gfi1, Csf1r, and Csf2ra)-, E (Gata1 and Klf1)-, 
and HSC (Hoxb4, Bmi1, Meis1, and Cxcr4)-associated genes. 
We observed a 50% increase in proportion of cells express-
ing one or more E genes (Fig. 3 E). In addition, the average 
expression of E genes in these cells was increased (1.8-fold, 
P = 0.10), with a similar decrease in the average expression of 
GM genes (1.7-fold, P = 0.008; Fig. 3 F). Importantly, we con-
sistently observed coexpression of E genes with one or more 
GM genes, as well as HSC-associated genes, consistent with 
the increase in E programming occurring in multipotent stem/ 
progenitor cells, rather than through the expansion of a sub-
population of committed erythroid progenitors.
To establish if Epo-induced reprogramming of stem/pro-
genitor cells resulted in skewing of their lineage output, we 
transplanted control and Epo-exposed HSCs (defined as 
LSKFlt3CD150+; CD45.2 allotype) into sublethally irradi-
ated CD45.1 recipients. Transplanted HSCs were isolated 
from CD45.2 miR144/451eGFP/+ mice. This strain contains an 
EGFP knockin into a microRNA locus uniformly expressed in 
E lineage cells, including circulating mature erythrocytes, allow-
ing for EGFP-based tracking of E lineage output (Rasmussen 
and O’Carroll, 2011; Mancini et al., 2012; Fig. 4 A). Analysis 
of peripheral blood showed that Epo-exposed HSCs gener-
ated significantly higher numbers of erythrocytes (Fig. 4, B 
and C) and fewer myeloid cells (Fig. 4 D). Overall, a fourfold 
increase of the erythroid/myeloid output ratio was observed. 
colony-forming cells (Fig. 1 C). Therefore, at all known lin-
eage bifurcations between HSCs and committed E progenitors, 
elevated Epo levels impaired the formation of progenitor cells 
lacking E potential (LMPP, preGM/GMP, and MkP), selec-
tively promoting the formation of E committed progenitors 
(CFU-E and preCFU-E), and this process is initiated within 
the HSC/MPP compartment.
Previous studies have shown that the transcriptional prim-
ing of HSCs is an indicator of their lineage potential, and that 
the priming pattern is regulated by the transcription factors 
required for subsequent lineage commitment (Bereshchenko 
et al., 2009; Mancini et al., 2012). To determine whether Epo 
exposure alters the priming pattern of stem and progenitor 
cell populations, we mined existing global gene profiling data 
(Pronk et al., 2007) to identify gene sets highly and selectively 
expressed in preGMs, preCFU-Es, MkPs, and common lym-
phoid progenitors (CLPs), representing the first GM, E, Mk, 
and lymphoid committed progenitors, respectively (Fig. S1). 
Gene profiling of in vivo Epo-exposed LSKFlt3 cells showed 
that genes associated with E lineage commitment were up-
regulated, whereas those associated with Mk and GM lineage 
commitment were down-regulated (Fig. 2 A). This occurred 
without any change to the size or composition of the HSC 
compartment (Fig. 2, B and C), to the cell cycle status of 
HSC/MPPs (Fig. 2 D), or to HSC repopulating activity (not 
depicted). Downstream of HSCs, bipotent preMegEs had up-
regulated preCFU-E genes, whereas most MkP gene expression 
was suppressed (Fig. 2 E), consistent with the observed ery-
throid bias at the MkP/preCFU-E bifurcation. LMPPs showed 
general down-regulation of CLP and preGM genes (Fig. 2 F). 
The decrease in LMPP lymphoid gene expression was ac-
companied by suppressed LMPP B cell differentiation poten-
tial (Fig. 2 G), and a decreased number of downstream CLPs 
(Fig. 2 H). The effect of Epo on GM and T cell potential of 
LMPPs remains to be determined. Lineage programming of 
stem/progenitor cells was therefore regulated by Epo, and cor-
related with altered lineage potential and progenitor output.
To address if Epo acts directly and instructively on the 
HSC/MPP compartment, we isolated LSKCD150+Flt3 cells 
and treated these with recombinant Epo in vitro. We observed 
a virtually identical pattern of regulation of lineage program-
ming as seen upon in vivo Epo exposure (Fig. 3 A). To deter-
mine if endogenous erythropoietic stress would cause similar 
transcriptional HSC reprogramming, CD45.2 Gata1 condi-
tional null (or control) cells (CD45.2) were co-transplanted 
with wild-type CD45.1 cells into lethally irradiated CD45.1/2 
hosts at a 10:1 ratio, followed by Gata1 deletion through 
poly(I-C) induction of the Mx1-Cre transgene. This selectively 
blocks erythropoiesis at the preMegE stage (Mancini et al., 2012), 
leading to a selective increase in circulating Epo levels (Fig. 3 B) 
and forcing the wild-type CD45.1 HSCs present along Gata1- 
deficient CD45.2 HSCs to generate 10× more erythrocytes 
on a per-cell basis. 6 wk later, CD45.1 LSKFlt3 HSC/MPPs 
were isolated and gene profiled. This showed that CD45.1 
LSKFlt3 cells present along Gata1-deficient CD45.2 cells up- 
regulated erythroid genes and concomitantly suppressed preGM 
JEM Vol. 211, No. 2 185
Br ief Definit ive Repor t
Figure 3. Cellular and molecular mechanism of Epo action on HSCs. (A) LSKFlt3CD150+ cells were cultured in the presence (Epo) or absence 
(Control) of Epo. After 24 h, cells were harvested and analyzed for gene expression. Data are represented as in Fig. 2 A. Values are means, n = 2, from  
2 experiments with triplicate measurements. (B) Bar graph showing different serum cytokines levels in CD45.1/2 mice competitively transplanted with  
105 CD45.1 wild-type cells and either 106 CD45.2 Gata1fl/fl; Mx1-Cretg/+ (cKO) or 106 Gata1fl/fl BM cells (Con). Values are mean ± SD, n = 9 (control) and  
8 (cKO), from 2 experiments. (C) CD45.1/2 mice were competitively transplanted with 105 CD45.1 wild-type and either 106 CD45.2 Gata1fl/fl; Mx1-Cretg/+ 
(cKO) or 106 Gata1fl/fl BM cells (Con). Cre recombination was induced by three poly(I-C) injections at 2-d intervals, and CD45.1+CD45.2LSKFlt3CD150+ 
cells were isolated 6 wk after the first poly(I-C) injection and subjected to gene expression profiling. Data are represented as the log2 of the ratio between 
gene expression in WT/cKO and WT/Control co-transplanted mice after normalization to Hprt. Values are means, n = 2, from 2 experiments with triplicate 
measurements. (D) LSKFlt3CD150+ cells were cultured in the presence (Epo) or absence (Control) of Epo. For both conditions, individual cultures were 
supplied with either vehicle (DMSO) or inhibitors of one of the following kinases: 25 µM Jak2 (AG490), 25 µM PI3K (LY294002), or 25 µM ERK1/2 
(PD98059). After 24 h, cells were harvested and analyzed for gene expression. Values are means, n = 2, from 2 experiments with triplicate measurements. 
(E) Heat map of gene expression in single sorted LSKFlt3 HSCs analyzed by microfluidics-based real time PCR. Expression values were normalized using 
Kit expression and are shown as deviation from the mean expression value of each individual gene. n = 3 from 3 experiments. (F) Bar graph of mean ex-
pression of GM-, E-, and HSC-associated genes in single cells from E. Values represent the mean (Ct(gene)Ct(Kit)) for each of the genes indicated, 
including only cells where expression was detected. ***, P < 0.0005.
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Exposure of HSC/MPPs to Epo is therefore sufficient to bias 
lineage output away from the myeloid lineage and toward 
erythropoiesis, even in the absence of exogenous Epo during 
their further lineage commitment and differentiation.
These results challenge our current view of lineage-specific 
cytokine action in two ways. First, they show that Epo can act 
on HSC/MPPs, in addition to E lineage–committed cells, to 
simultaneously increase E and decrease GM output. Second, 
we find that this occurs through transcriptional reprogram-
ming, leading to increased E lineage priming and decreased 
GM, Mk, and lymphoid priming, and the systematic suppres-
sion of alternative lymphoid and myeloid lineage options at 
all lineage bifurcations examined. Up-regulation of erythroid 
gene expression showed a strong dependence on PI3 kinase 
signaling. In contrast, Erk signaling was critical for myeloid 
gene suppression; if Erk activity was blocked, Epo stimulation 
led to a general up-regulation of myeloid gene expression. 
This dissociation of lineage reprogramming is consistent with 
an instructive, rather than selective, effect of Epo on the HSC 
compartment; Epo exposure could lead to the selective ex-
pansion or survival of cells expressing high levels of preCFU-E 
and low levels of MkP and preGM genes. However, this model 
is not readily reconciled with the ability of simultaneous Epo 
stimulation and Erk inhibition to up-regulate CFU-E and 
preGM genes and suppress MkP genes. Our results therefore 
show that the high systemic levels of Epo associated with se-
vere anemia can act in a direct and instructive manner on the 
HSC/MPP compartment, leading to a reduction of GM, Mk, 
and lymphoid phenotypic progenitors and colony-forming cells. 
The overall result is the creation of enhanced throughput 
from HSCs to the E compartment, an “erythroid superhigh-
way,” allowing the focused generation of E-lineage progeni-
tors (Fig. 4 E), upon which Epo may then further act through 
its well-characterized proliferative and pro-survival effects.
MATERIALS AND METHODS
Mouse lines. C57BL/6J (CD45.2+) mice and congenic B6.SJL-PtprcaPep3b/
BoyJ (CD45.1+ congenic C57BL/6J) mice were bred at the University of 
Edinburgh. The Gata1 conditional allele (Lindeboom et al., 2003), Mx1-Cre 
transgenic mice (Kühn et al., 1995), and mir144/451-eGFP reporter mice 
(Rasmussen and O’Carroll, 2011) were previously described. Mouse strains 
were backcrossed to C57Bl6/J for six or more generations before use, and 
mice were aged 8–12 wk at the start of experiments. All animal procedures 
were approved by the University of Oxford Clinical Medicine Ethical Re-
view Committee and were maintained in accordance with Institutional and 
UK Home Office guidelines.
Hydrodynamic gene transduction and ELISA. Mice were tail vein– 
injected, as described previously (Hirai et al., 2006), in Krebs-Ringer buffer 
with 1 µg of a pCMV6-Entry vector containing Epo cDNA (OriGene) or 
empty pCMV6-Entry vector. Epo, Thrombopoietin, and G-CSF serum levels 
were determined using Quantikine immunoassays (R&D Systems).
Figure 4. Epo-exposed HSCs generate reduced myeloid lineage 
output and increased erythroid lineage output. (A) LSKFlt3CD150+ 
cells were isolated from Epo-exposed or control miR144/451Egfp/+ mice 
and transplanted into sublethally irradiated CD45.1 recipients, followed  
by peripheral blood analysis 28 d after transplantation. (B) Representa-
tive flow cytometric analysis of peripheral blood erythrocytes from 
CD45.1 recipients transplanted in A. The gated population shows the 
Ter119+EGFP+ donor-derived erythrocytes. The size of gated populations 
as a percentage of the parental population is shown next to gates.  
(C and D) Bar graphs representing the mean percentage of donor-derived 
Ter119+EGFP+ PB erythrocytes and CD45.2+Mac-1+ PB cells, respectively, 
from mice transplanted in A. Values are mean ± SD, n = 9 (control) and 
12 (Epo), from 2 experiments. (E) The overall effect of Epo exposure on the 
hematopoietic hierarchy: generation of LMPP/CLP, preGM, and MkP pro-
genitors is impaired, leading HSC output to be directed toward the E lin-
eage by blocking alternative exits from the HSC compartment. The result 
is an erythroid superhighway from the HSC to the preCFU-E.
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et al., 2009). Genes differentially expressed between progenitor subsets (CLP, 
preGM, preMegE, MkP, and preCFU-E) were manually curated to identify 
those selectively and highly expressed in each of the following populations: 
CLP, preGM, MkP, and preCFU-E (Table S1).
Statistical analyses. Statistical significance for all the data was calculated 
using Student’s t test.
Online supplemental material. Lineage-specific genes and their normal-
ized expression values are found in Fig. S1 and Table S1. Gating strategies 
for OP9 cultures and CLPs are shown in Fig. S2. Table S2 contains DEL-
TAGene assays used in single-cell PCR, and Table S3 the list of antibody 
conjugates used. Online supplemental material is available at http://www 
.jem.org/cgi/content/full/jem.20131189/DC1.
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